Virtual screening of the Janssen compound collection against SARS-CoV-2 Mpro

Van Damme, Ellen

doi:10.5281/zenodo.5838705

Published January 11, 2022 | Version v1

Dataset Open

Virtual screening of the Janssen compound collection against SARS-CoV-2 Mpro

Van Damme, Ellen¹

1. Janssen Pharmaceutica NV

This short report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 Mpro and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.

Files

Files (60.5 kB)

Name	Size	Download all
Virtual screening of the Janssen compound collection against SARS-CoV-2 Mpro.xlsx md5:84cdbbe3d040363cdc1bfc0b6de627e4	60.5 kB	Download

326

Views

Downloads

Show more details

	All versions	This version
Views	326	323
Downloads	15	15
Data volume	906.8 kB	906.8 kB

More info on how stats are collected....

DOI

Resource type

Dataset

Publisher

Zenodo

Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more

Technical metadata

Created: January 11, 2022
Modified: January 12, 2022

Virtual screening of the Janssen compound collection against SARS-CoV-2 Mpro

Creators

Description

Files

Files (60.5 kB)